The detection of diseases at an early stage of development provides many benefits, such as timely and specific treatment with considerable cost savings and the ability to trace the cause of an illness. To support the progress of early diagnostics, VITO focuses on the development of diagnostic assays and technologies, and on the identification of new biomarkers. We do this in close collaboration with academic partners, health experts and the pharmaceutical and biotech industries.

Publications

Characterization of Gold Nanorods Conjugated with Synthetic Glycopolymers Using an Analytical Approach Based on spICP-SFMS and EAF4-MALS
Year: 
2021
Journal: 
NANOMATERIALS
Velimirovic, M; Pancaro, A; Mildner, R; Georgiou, PG; Tirez, K; Nelissen, I; Johann, C; Gibson, MI; Vanhaecke, F
Ion Mobility Coupled to a Time-of-Flight Mass Analyzer Combined With Fragment Intensity Predictions Improves Identification of Classical Bioactive Peptides and Small Open Reading Frame-Encoded Peptides
Year: 
2021
Journal: 
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Peeters, MKR; Baggerman, G; Gabriels, R; Pepermans, E; Menschaert, G; Boonen, K
An In Vitro Air-Liquid Interface Inhalation Platform for Petroleum Substances and Constituents
Year: 
2021
Journal: 
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION
Verstraelen, S; Jacobs, A; Van Laer, J; Hollanders, K; Van Deun, M; Bertels, D; Brabers, R; Witters, H; Remy, S; Geerts, L; Deferme, L; Frijns, E
Alternative indications for corneal crosslinking
Year: 
2021
Journal: 
JOURNAL OF CATARACT AND REFRACTIVE SURGERY
Van Tigchelt, L; Van Eijgen, J; Delbeke, H
The peppermint breath test benchmark for PTR-MS and SIFT-MS
Year: 
2021
Journal: 
JOURNAL OF BREATH RESEARCH
Henderson, B; Slingers, G; Pedrotti, M; Pugliese, G; Malaskova, M; Bryant, L; Lomonaco, T; Ghimenti, S; Moreno, S; Cordell, R; Harren, FJM; Schubert, J; Mayhew, CA; Wilde, M; Di Francesco, F; Koppen, G; Beauchamp, JD; Cristescu, SM

Pages